Navigation Links
Nasal polyps from analgesics
Date:3/10/2008

If a patient develops respiratory problems after taking analgesics, this indicates that the active substances are poorly tolerated. This is pointed out by Prof. Hanns-Wolf Baenkler, Erlangen University Medical School, in the current edition of the Deutsches rzteblatt International (Dtsch Arztebl Int 2008; 105(8): 13742). One should also think of analgesic intolerance when patients suffer from chronic irritation of the gastrointestinal tract, without any recognizable allergy or infection.

Patients with these symptoms exhibit enhanced sensitivity and changes in the pattern of the so-called eicosanoids - important mediators of pain and inflammation. This change in pattern explains the specific reaction to salicylates and related COX inhibitors in analgesics, cosmetics, and vegetable foods. The classical symptoms of intolerance are rhinitis, bronchial asthma or nasal polyps, accompanied by inflammatory reactions in the intestine or skin and urticaria.

The diagnosis is based on symptoms immediately after taking salicylates or on recurrent polyp formation. Blood tests can be an important diagnostic aid, particularly in difficult cases. Discontinuation of treatment helps, as does corticosteroid treatment. Biological treatment is also possible, based on adaptation by administering increasing doses of acetylsalicylic acid.


'/>"/>

Contact: Dr. Stephan Mertens
stephan.mertens@aerzteblatt.de
Deutsches Aerzteblatt International
Source:Eurekalert

Page: 1

Related medicine news :

1. Saline Nasal Wash Helps Kids Fight Colds, Flu
2. Protein Nasal Spray Revives Sleep-Deprived Monkeys
3. Saline Irrigation Eases Chronic Nasal Symptoms
4. New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis
5. U.S. Advisers OK Nasal Spray Flu Vaccine for Young Children
6. As Cold & Flu Season Nears, New Baby Nasal Aspirator Offers Safe and Effective Alternative to FDA-Discouraged Medicines
7. Nosefrida Nasal Aspirator - A Parents Alternative to Medicines on the Verge of FDA Ban
8. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
9. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
10. Nasal Anthrax Vaccine Proves Effective in Animal Study
11. Smoking can double risk of colorectal polyps
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... Lori R. Somekh, founder of the Law Office ... of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office ... forum to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... are now treating sleep apnea using cutting-edge Oventus O2Vent technology. As ... serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can offer ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... 11, 2017  Caris Life Sciences ® , a ... promise of precision medicine, today announced that St. Jude ... Oncology Alliance™ (POA) as its 17 th member. ... Jude Crosson Cancer Institute will help develop standards of ... tumor profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
Breaking Medicine Technology: